Understanding where your facility stands relative to national norms is foundational to running a well-managed treatment center. Behavioral health admissions benchmarks give operators a data-grounded basis for evaluating performance, setting targets, and making the case for operational changes to ownership or boards. Here’s what the publicly available data shows heading into 2026—and what it means for facility operators.
Primary Data Sources for Benchmarking
Two federal databases provide the most reliable aggregate benchmarks for treatment centers:
- SAMHSA’s Treatment Episode Data Set (TEDS): Collects admission and discharge data from state-funded treatment facilities. Updated annually, TEDS is the most comprehensive longitudinal dataset on admissions patterns, including demographics, primary substance, referral sources, and length of stay.
- National Survey of Substance Abuse Treatment Services (N-SSATS / BHSIS): An annual facility-level census that captures service offerings, payer acceptance, capacity, and utilization. This is where bed utilization benchmarks come from.
Both datasets are publicly available through SAMHSA’s Behavioral Health Data and Statistics portal.
Bed Utilization: The Core Capacity Metric
National average bed utilization rates for residential substance use treatment facilities typically run in the 70–80% range, based on N-SSATS data. However, this varies significantly by:
- Level of care: Detox and acute residential programs tend to run at higher utilization (80–90%) due to shorter stays and urgent placement needs. Long-term residential and transitional programs often run lower (60–75%).
- Region: States with limited treatment capacity relative to demand (rural states, states with large Medicaid expansions) tend to see higher utilization rates. Dense urban markets with multiple providers may run lower.
- Payer mix: Facilities with broader insurance acceptance tend to have higher and more stable utilization than those dependent on self-pay or a narrow payer mix.
A useful benchmark: if your residential program is running below 70% occupancy consistently, that’s a signal to investigate—whether the issue is referral pipeline, insurance access, geographic reach, or competitive dynamics.
Length of Stay Trends
TEDS data shows median lengths of stay have been compressing across most levels of care over the past decade, driven by payer pressure and a shift toward step-down models:
- Detox/withdrawal management: Typically 5–7 days for alcohol; 3–5 days for opioids with MAT initiation
- Short-term residential: Median around 30 days, down from 45-60 days in earlier periods
- Long-term residential: Wide variance, typically 90–180 days
- IOP: Typically 8–12 weeks for standard programs; clinical outcomes data generally supports 90+ days of engagement
For operators, length of stay has direct revenue implications. Shorter stays increase throughput but may reduce revenue per admission if your contracts reimburse on a per-diem basis. Longer stays improve clinical outcomes but require strong UM support to justify to commercial payers.
Readmission Rates and Treatment Continuity
TEDS data shows that a significant percentage of treatment admissions—roughly 40–60% depending on the substance and population—involve patients with prior treatment episodes. This reflects the chronic, relapsing nature of substance use disorders rather than treatment failure per se.
For operators, readmission rates are a double-edged metric: high rates can indicate effective alumni engagement and continuity of care relationships, or they can indicate inadequate step-down planning. Tracking your own readmission patterns relative to the national baseline helps distinguish these scenarios.
Payer Mix Trends
One of the most significant structural trends visible in N-SSATS data over the past decade is the shift in payer mix toward public insurance (Medicaid in particular), driven by the ACA Medicaid expansion and MHPAEA enforcement. Nationally, Medicaid now funds a plurality of admissions at facilities that accept it. Facilities that expanded Medicaid contracting in expansion states consistently showed census growth in the years following expansion.
From National Benchmarks to Local Intelligence
National and state-level benchmarks tell you where the industry is—not where your specific market is. Your local competitive dynamics may differ significantly from national averages. GTH’s free Growth Gap Audit pre-processes SAMHSA facility data to give you a local benchmark: how does your facility compare to the 5 nearest competitors on insurance, services, and visibility?
Frequently Asked Questions
How often is TEDS data updated?
TEDS data is published annually, typically with an 18–24 month lag from the reference year. The most recent available year is usually 2022 or 2023 as of 2026. State-level data may be available more recently through state behavioral health agencies.
Can I access facility-specific benchmark data?
SAMHSA does not publish facility-specific data in a way that enables direct comparison. N-SSATS data can be downloaded at the facility level (with facility identifiers for participating facilities), but analysis requires technical capability. Pre-processed tools like GTH’s audit make this accessible without data science resources.
What’s a realistic benchmark for IOP enrollment?
This varies significantly by population and market. A starting benchmark: if your IOP has licensed capacity of 30 slots and averages fewer than 20 active patients, that’s underutilization worth investigating. Common causes include referral gaps, insurance barriers, or competition from facilities with broader payer acceptance.
For immediate help connecting patients with treatment, refer them to the SAMHSA National Helpline: 1-800-662-4357 (free, confidential, 24/7).